Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: AHF (High Purity) Dried Factor VIII Fraction
Active Ingredient: Factor VIII, human 250IU
Dosage Form: Powder for injection
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia
Note: This consent is valid for two years from 25 February 2003.
Dated this 9th day of September 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).